April 24, 2019 | Michael Easterling and Samantha Bonar
City of Hope’s bone marrow transplant program recently performed the procedure on its 15,000th patient, a remarkable milestone considering that the initiative started with just two physicians, three beds and guarded expectations in 1976.
International diabetes experts converge for Levine-Riggs symposium
April 23, 2019 | Michael Easterling
More than 250 physicians and scientists from around the world attended the 2019 City of Hope Levine-Riggs Diabetes Research Symposium, held April 10 to 13 at The Westin Hotel in Pasadena, California.
City of Hope study finds diabetes A1c test misses most cases
March 28, 2019 | City of Hope
The hemoglobin A1c blood test is widely used to diagnose type 1 and type 2 diabetes but it is actually unable to detect the disease in most patients, according to a new study presented March 23 at the Endocrine Society’s annual meeting.
Landmark human insulin study marks 40-year anniversary
January 29, 2019 | Michael Easterling
In January 1979, the National Academy of Sciences published a paper about an innovative discovery at City of Hope that would forever change how diabetes is treated. Arthur Riggs, Ph.D., and Keiichi Itakura, Ph.D., revolutionized diabetes treatment when they made a novel gene, one that coded for human insulin.
Researchers identify new target for potential type 1 diabetes treatment
October 18, 2018 | Katie Neith
Recently a team of researchers led by City of Hope scientists identified a new potential target to keep the immune system stable and islet beta cells healthy, in an effort to keep type 1 diabetes at bay.
The Wanek Family Project to Cure Type 1 Diabetes: 18 months later
August 9, 2018 | Dory Benford
Last year, the City of Hope Wanek Family Project to Cure Type 1 Diabetes launched 16 projects across multiple disciplines, including immunology, endocrinology, cellular therapeutics, nutrition and metabolism. Now, 18 months in, we are pleased with our progress and more optimistic than ever about finding a cure.
City of Hope Aims to Cure Type 1 Diabetes in Six Years
July 11, 2017 | City of Hope
City of Hope’s Diabetes & Metabolism Research Institute is committed to developing a cure for type 1 diabetes within six years, fueled by a $50 million funding program led by the Wanek family.
Bart Roep, Ph.D., Has Type 1 Diabetes Cure in His Sights
June 27, 2017 | Samantha Bonar
Bart O. Roep, Ph.D., has dedicated his life to the search for a cure for type 1 diabetes. And he thinks he is on the brink. Roep, an internationally renowned immunologist who joined City of Hope last year from the Netherlands’ Leiden University Medical Center, was recently named the Chan Soon-Shiong Shapiro Distinguished Chair in Diabetes. He believes that this endowment and a $50 million funding project led by the Wanek family will be key in stopping the disease.
The enduring legacy of City of Hope’s Japanese-American scientists
June 6, 2017 | Letisia Marquez
City of Hope’s rich history is filled with stories of celebrated researchers who helped shape the course of modern medicine. Yoko Fujita-Yamaguchi, Ph.D., professor emeritus in the Diabetes & Metabolism Research Institute at City of Hope, has written a book in Japanese that delves into the contributions of Japanese-American scientists at City of Hope.